---
title: Aragen Life Sciences vs uBriGene
slug_a: aragen
slug_b: ubrigene
site: cro
review_signal_gate: closed
canonical_path: /compare/aragen/ubrigene
generated_by: BioBM Editorial AI
---

# Aragen Life Sciences vs uBriGene

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Aragen Life Sciences (aragen) is listed for cro. Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.

Services: 32. Modalities: 10. Indications: 14. Locations: 20. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (32).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

uBriGene (ubrigene) is listed for both. uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.